SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Rachel Carson — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientRachel Carson
Date of birth1907-05-27
IdentifiersMRN HR-ML041-SYN-TD; SSN (made up) 000-41-5068
Document date1960-10-13
AuthorMargaret Vance-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Ms. Carson returns for her yearly preventive visit, in her fifth ribociclib cycle and four months into letrozole. The cold in July settled in about a week without antibiotics. She has mild morning stiffness in her knees, eased by walking, and occasional hot flashes at night. She finished the draft of her book last month and is now revising it. She completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 53
Active conditionsLeft breast cancer after lumpectomy and radiation, on letrozole, ribociclib, and zoledronic acid; low bone mass; knee osteoarthritis
MedicinesLetrozole 2.5 mg daily; ribociclib 400 mg on days 1 to 21 of each cycle; zoledronic acid every six months; vitamin D3 1000 units daily; acetaminophen as needed
Recent eventsViral rhinosinusitis in July, resolved
Functional statusIndependent; walking 30 minutes most days

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, and better than she expected during treatment
PsychosocialA close friend and her editor are her main supports; no financial strain; feels safe at home; shares her diagnosis with a few people of her choosing
BehavioralNever smoker; a small glass of sherry a few times a month; walks most days; eats fish, vegetables, and dairy
Activities of daily livingIndependent in all
Instrumental activities of daily livingManages her own medicines, money, correspondence, and household
Home safetySmoke detectors working; wears a seat belt; no falls
Hearing and visionReading glasses; eye examination last year; hearing normal
SleepAbout seven hours a night, sometimes woken by a hot flash

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight stable; no fever or night sweats beyond hot flashes
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeSinus symptoms resolved
CardiovascularNegativeNo chest pain, palpitations, fainting, or leg swelling
RespiratoryNegativeNo cough or breathlessness
BreastNegativeNo new lump in either breast; left breast firmer since radiation
GastrointestinalNegativeNo indigestion, black stools, or diarrhea
GenitourinaryPositiveMild vaginal dryness; no bleeding or urinary symptoms
MusculoskeletalPositiveMorning knee stiffness for about 15 minutes; no bone pain
IntegumentaryNegativeNo rash; radiation skin healed
NeurologicalNegativeNo headaches or numbness
PsychiatricNegativeMood good; PHQ-2 score 0

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth once daily before breakfast, to complete eight weeks of ulcer healingOne capsule once daily before breakfastOral route1960-01-19 to 1960-04-03completedS
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for knee pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route1959-06-02activeS
Letrozole 2.5 mg oral tablet, one tablet by mouth once daily, planned for at least five yearsOne tablet once dailyOral route1960-06-15activeS
Ribociclib 200 mg oral tablet, two tablets (400 mg) by mouth once daily on days 1 to 21 of each 28-day cycle, with letrozole, planned for three yearsTwo tablets once daily on days 1 to 21 of each 28-day cycleOral route1960-06-15activeS
Zoledronic acid 4 mg in 100 mL intravenous infusion over 15 minutes every six months for three yearsOne infusion every six monthsIntravenous route1960-06-15activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route1960-06-15activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1960-10-13Body height163cmS
1960-10-13Body weight59.8kgS
1960-10-13Body mass index (BMI) [Ratio]22.5kg/m2S
1960-10-13Systolic blood pressure116mm[Hg]S
1960-10-13Diastolic blood pressure74mm[Hg]S
1960-10-13Heart rate70/minS
1960-10-13Respiratory rate14/minS
1960-10-13Body temperature36.6CelS
1960-10-13Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1960-10-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1960-10-13Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 1960-10-13; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell-appearing; BMI 22.5
EyesPupils equal and reactive
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm; no murmur; no edema
RespiratoryClear
BreastsLeft lumpectomy scar healed; mild firmness and tanning of the treated breast from radiation; no masses in either breast
Lymph nodesNo axillary or supraclavicular nodes
ExtremitiesArm circumference 25.5 cm on each side 10 cm above the elbow; full shoulder movement; knees with mild crepitus and no effusion
AbdomenSoft; no epigastric tenderness; liver not enlarged
SkinNo suspicious lesions
PsychiatricBright, precise, and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left breast, upper outer quadrant at 2 o'clock, 2.4 cm on imaging; core biopsy grade 2, estrogen and progesterone receptor positive, HER2 negative, Ki-67 22 percent; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern counterpart of the documented 1894 breast cancer, which was not disclosed to heractiveconfirmed C50.412S — Synthetic tumor details, stage, and treatment; the breast lumps, the 1960 operation, and the nondisclosure are documented (D), but no tumor details from her lifetime are used.
Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 80 percent)activeconfirmed Z17.0S — Synthetic receptor result; no receptor status from her lifetime is known.
New firm lump in the upper outer quadrant of the left breast, found two weeks ago; clinically suspicious; diagnostic imaging and biopsy bookedresolvedconfirmed N63.21S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the lumps in the left breast in early 1960 are documented (D).
Duodenal ulcer found at endoscopy seven weeks ago, with Helicobacter pylori on biopsy; treated with 14 days of bismuth quadruple therapy and completing eight weeks of omeprazole; test of cure plannedresolvedconfirmed K26.9S — Synthetic modern ulcer; it echoes the ulcer among her documented illnesses, which the sources do not date.
Primary osteoarthritis of both knees, mild, with stiffness after long walks on the shoreactiveconfirmed M17.0S — Synthetic condition; it is not linked to the documented word arthritis, which she may have used to keep her cancer private.
Metastatic carcinoma in two of three left axillary sentinel lymph nodes (macrometastases, no extranodal extension); pathologic stage pT2 pN1a(sn) M0, anatomic stage IIB; recurrence score 17activeconfirmed C77.3S — Synthetic surgical pathology; spread to lymph nodes is documented later in her life, but no pathology from her lifetime is used.
Long-term use of letrozole as adjuvant endocrine therapy, with ribociclib for three yearsactiveconfirmed Z79.811S — Synthetic treatment status.
Low bone mass (osteopenia) on baseline DXA before letrozole: lumbar spine T-score -1.8, femoral neck -1.3; 10-year major osteoporotic fracture risk about 7 percent (FRAX); vitamin D insufficiencyactiveconfirmed M85.80S — Synthetic finding on the baseline DXA the protocol requires for an aromatase inhibitor.
Acute viral rhinosinusitis for five days while on ribociclib, with expected grade 2 neutropenia (absolute neutrophil count 1.2) and no fever; resolved with saline irrigationresolvedconfirmed J01.90S — Synthetic common illness; it echoes the sinus infection among her documented illnesses, which the sources do not date, and is not linked to that claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 1960-1961Completed todayInactivated vaccine given today
Pneumococcal vaccineCompleted todayPCV20 given today; recommended from age 50; no further doses needed
Recombinant zoster vaccineCompleted todayDose 1 today; dose 2 in two to six months; not a live vaccine, so suitable during treatment
COVID-19 vaccine, 1960-1961DueRecommended; she will get it at her pharmacy in two weeks
Hepatitis B vaccineDueRecommended for adults 19 to 59; series to start at the next visit if the screening test shows no immunity
Tetanus boosterUp to dateTdap five years ago
Breast cancer screeningNot indicatedReplaced by surveillance: bilateral diagnostic mammogram six to twelve months after radiation, then yearly
Cervical cancer screeningUp to dateCytology with HPV co-testing two years ago, normal; next in three years
Colorectal cancer screeningUp to dateColonoscopy three years ago, normal; next at ten years
Osteoporosis screeningUp to dateDXA four months ago: low bone mass; on zoledronic acid; repeat in two years
Hepatitis B, hepatitis C, and HIV screeningOrderedOne-time screening; no prior result on record; drawn today, results pending
Cholesterol screening and statin decisionCompleted todayLipid panel four months ago reviewed; 10-year risk below 5 percent; no statin
Diabetes screeningNot indicatedBMI 22.5 without other risk factors
Lung cancer screeningNot indicatedNever smoker
Blood pressure screeningCompleted today116/74 mmHg
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 1, negative
Physical activity and diet counselingCompleted today150 minutes of walking a week, strength exercise twice a week for bone and knees, calcium from food, and alcohol at or below one drink a day

Immunizations given today: Influenza vaccine, 1960-1961 season; Pneumococcal conjugate vaccine PCV20; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Hepatitis B, hepatitis C, and HIV results by portal message. Second zoster dose in two to six months. Survivorship visit in three months; next zoledronic acid infusion in December; mammogram six to twelve months after radiation. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She has named a health care agent, a close friend, and completed a written health care directive today, now scanned into the chart. Her first instruction is that she is always to be told the truth about her condition, directly and in plain words, and that her clinicians must never withhold a diagnosis or a result from her or tell it to others first. Her treatment is curative in intent. If the cancer returned, she would want treatment that let her keep working and living independently; she would not want resuscitation or prolonged life support if recovery to independent life were not expected. [S]